14:16 ET Teva Pharm gets summary judgment for invalidity of patent (TEVA) 67.45 +0.25: Announces that a U. S. District Court judge has granted TEVA's motion for summary judgment of invalidity finding a patent relating to the generic equivalent of ABT's Vicoprofen; the FDA has been informed of the judge's order and the co is hopeful that its ANDA will receive final approval shortly.